STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands.
Bang for Buck Consulting, Amsterdam, The Netherlands.
Sex Transm Infect. 2018 May;94(3):174-179. doi: 10.1136/sextrans-2017-053159. Epub 2017 Sep 23.
Point-of-care (POC) management may avert ongoing transmissions occurring between testing and treatment or due to loss to follow-up. We modelled the impact of POC management of anogenital gonorrhoea (with light microscopic evaluation of Gram stained smears) among men who have sex with men (MSM) on gonorrhoea prevalence and testing and treatment costs.
Data concerning costs and sexual behaviour were collected from the STI clinic of Amsterdam. With a deterministic model for gonorrhoea transmission, we calculated the prevalence of gonorrhoea in MSM in Amsterdam and the numbers of consultations at our clinic over 5 years, in three testing scenarios: POC for symptomatic MSM only (currently routine), POC for all MSM and no POC for MSM.
Among MSM, 34.7% (109/314) had sexual contacts in the period between testing and treatment, of whom 22.9% (25/109) had unprotected anal intercourse. Expanding POC testing from symptomatic MSM to all MSM could result in an 11% decrease (IQR, 8%-15%) in gonorrhoea prevalence after 5 years and a cost increase of 8.6% (€2.40) per consultation and €86 118 overall (+8.3%). Switching from POC testing of symptomatic MSM to no POC testing could save €1.83 per consultation (6.5%) and €54 044 (-5.2%) after 5 years with a 60% (IQR, 26%-127%) gonorrhoea prevalence increase. Overtreatment was 2.1% (30/1411) with POC for symptomatic MSM only and 4.1% (68/1675) with POC for all MSM.
In the Amsterdam setting, possible abandonment of POC testing of symptomatic MSM because of budget cuts could result in a considerable increase in gonorrhoea prevalence against a reduction in costs per consultation. Expanding POC testing to all MSM could result in a modest reduction in prevalence and a cost increase. While the costs and outcomes depend on specific local characteristics, the developed framework of this study is useful to evaluate POC management in other settings.
即时检测(POC)管理可以避免在检测和治疗之间或因失访而发生的持续传播。我们通过对男男性行为者(MSM)进行肛门生殖器淋病(用革兰氏染色涂片进行光学显微镜评估)的即时检测管理,对淋病发病率和检测及治疗成本进行建模。
我们从阿姆斯特丹的性传播感染(STI)诊所收集有关成本和性行为的数据。通过淋病传播的确定性模型,我们计算了阿姆斯特丹 MSM 中的淋病流行率,以及在 5 年内我们诊所的就诊人数,在三种检测情况下:仅对有症状的 MSM 进行 POC(当前常规),对所有 MSM 进行 POC,对 MSM 不进行 POC。
在 MSM 中,34.7%(109/314)在检测和治疗期间有性接触,其中 22.9%(25/109)有未保护的肛交。将 POC 检测从有症状的 MSM 扩展到所有 MSM,可能会导致 5 年后淋病发病率下降 11%(IQR,8%-15%),每次就诊成本增加 8.6%(€2.40),总计增加€86118(+8.3%)。从有症状的 MSM 的 POC 检测转换为无 POC 检测,可节省每次就诊的€1.83(6.5%)和 5 年后的€54044(-5.2%),同时淋病发病率增加 60%(IQR,26%-127%)。仅对有症状的 MSM 进行 POC 检测的过度治疗率为 2.1%(30/1411),而对所有 MSM 进行 POC 检测的过度治疗率为 4.1%(68/1675)。
在阿姆斯特丹的环境中,由于预算削减,可能放弃对有症状的 MSM 进行 POC 检测,可能会导致淋病发病率显著增加,而每次就诊的成本降低。将 POC 检测扩展到所有 MSM 可能会导致发病率略有下降,成本增加。虽然成本和结果取决于特定的本地特征,但本研究中开发的框架可用于评估其他环境中的即时检测管理。